JPH0443065B2 - - Google Patents

Info

Publication number
JPH0443065B2
JPH0443065B2 JP58086527A JP8652783A JPH0443065B2 JP H0443065 B2 JPH0443065 B2 JP H0443065B2 JP 58086527 A JP58086527 A JP 58086527A JP 8652783 A JP8652783 A JP 8652783A JP H0443065 B2 JPH0443065 B2 JP H0443065B2
Authority
JP
Japan
Prior art keywords
formula
compound
blood pressure
cyano
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58086527A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58213759A (ja
Inventor
Boruman Geruharuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS58213759A publication Critical patent/JPS58213759A/ja
Publication of JPH0443065B2 publication Critical patent/JPH0443065B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
JP58086527A 1982-05-18 1983-05-17 ２（１ｈ）−ピリジノン誘導体、その製造法、およびそれからなる医薬 Granted JPS58213759A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH3091/82-8 1982-05-18
CH308782 1982-05-18
CH3087/82-6 1982-05-18
CH837/83-4 1983-02-15

Publications (2)

Publication Number Publication Date
JPS58213759A JPS58213759A (ja) 1983-12-12
JPH0443065B2 true JPH0443065B2 (enrdf_load_stackoverflow) 1992-07-15

Family

ID=4248332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58086527A Granted JPS58213759A (ja) 1982-05-18 1983-05-17 ２（１ｈ）−ピリジノン誘導体、その製造法、およびそれからなる医薬

Country Status (3)

Country Link
JP (1) JPS58213759A (enrdf_load_stackoverflow)
BE (1) BE896678A (enrdf_load_stackoverflow)
ZA (1) ZA833584B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685840D1 (de) 1985-04-30 1992-08-06 Dresden Arzneimittel 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO760996L (enrdf_load_stackoverflow) * 1975-03-25 1976-09-28 Byk Gulden Lomberg Chem Fab
ZA807267B (en) * 1979-11-26 1981-11-25 Sterling Drug Inc 5-(pyridinyl)-2(1h)-pyridinones,useful as cardiotonic agents and their preparation
US4271168A (en) * 1979-12-26 1981-06-02 Sterling Drug Inc. Selected 3-acylamino-5-[4(or 3)-pyridinyl]-2(1H)-pyridinones
ZA821818B (en) * 1981-03-30 1983-02-23 Sterling Drug Inc 3-amino-5-(substituted)-2 (1h)-pyridinones and 3-cyano compounds useful as cardiotonics and preparation thereof

Also Published As

Publication number Publication date
ZA833584B (en) 1984-12-24
BE896678A (fr) 1983-11-07
JPS58213759A (ja) 1983-12-12

Similar Documents

Publication Publication Date Title
US4353905A (en) Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
SU1436872A3 (ru) Способ получени производных пиримидина
US4404203A (en) Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
JP2004359676A (ja) 置換チアゾリジンジオン誘導体
NL8100964A (nl) 2-(1h)pyridinon-derivaten en werkwijzen voor het bereiden van deze derivaten en van farmaceutische preparaten die ze bevatten.
JPS5822119B2 (ja) ジチオ−ル誘導体
US4530842A (en) 2(1H)-pyridinone derivatives, their preparation and pharmaceutical compositions containing them
HU202106B (en) Process for producing pharmaceutical compositions containing pyrazolin derivatives
JPH0443065B2 (enrdf_load_stackoverflow)
JPH0354668B2 (enrdf_load_stackoverflow)
JPH01500596A (ja) ピリドン‐ピリジル‐イミダゾリルおよびトリアゾリル化合物並びにそれらの強心薬としての使用
EP0194665A1 (en) beta-Adrenergic receptor agonist alkylaminoalkyl pyridinemethanol derivatives
JPS58210064A (ja) ジヒドロピリジン類の製法
JPS6041670B2 (ja) ２，６−ジメチル−１，４−ジヒドロピリジン−３，５−ジカルボン酸エステルおよびその製造方法
JPH01503456A (ja) ６‐（６‐アルキルピリドン）‐カルボスチリル化合物およびそれらの強心薬用法
JPS62240678A (ja) 複素環で置換されたベンズイミダゾ−ル、その製法及びこれを含有する心臓−及び循環疾病の治療剤
JPS584025B2 (ja) ４；− アルキルジオキシアルキレン −５− ベンジルピリミジン ノ セイホウ
JP3049816B2 (ja) 強心薬
JPS6136266A (ja) イソキノリン誘導体およびそれを有効成分として含有する治療用組成物
US3012032A (en) 2-[2-(4-pyridyl)-ethyl]-6-methyl-4, 5-dihydro-3-pyridazinone
SU1313346A3 (ru) Способ получени замещенных 6-арил-3(2 @ )-пиридазинонов
JPH0546338B2 (enrdf_load_stackoverflow)
KR940003362B1 (ko) 디히드로피리딘-5-포스폰산 고리형 프로필렌 에스테르
JP2000515117A (ja) 置換６―ｒ―１，３，４―チアジアジン―２―アミン、麻酔剤、心臓血管剤および代謝低下剤としてのそれらの使用、およびそれらを含有する医薬組成物
JPS60146873A (ja) ニコチノニトリル誘導体およびそれを有効成分として含有する治療用組成物